Position in GMAB
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$975,404
New position
Shares Held
36,355
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Integrated Quantitative Investments LLC holds $4,632,996 across 11 Biotechnology names. GMAB ranks #1 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
This page
|
36,355 | $975,404 | |
| 2 | TBPH |
Theravance Biopharma, Inc.
|
49,709 | $806,777 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,192 | $488,910 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
1,253 | $403,704 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
5,842 | $366,293 | |
| 6 | ALMS |
Alumis Inc.
|
15,423 | $339,768 | |
| 7 | ZVRA |
Zevra Therapeutics, Inc.
|
33,315 | $310,495 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
5,671 | $298,975 |
All Filings in GMAB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $975,404 | 36,355 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||